EDT.TO Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 22:59):

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America...

Stats
Объем за сегодня	56 923.00
Средний объем	86 594.00
Рыночная капитализация	133.72M
EPS	$0 ( 2024-03-25 )
Дата следующего отчета о доходах	( $0 ) 2024-05-09
Last Dividend	$0.120 ( 2011-12-19 )
Next Dividend	$0 ( N/A )
P/E	-8.00
ATR14	$0 (0.00%)

Spectral Medical Inc Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Spectral Medical Inc Финансовые показатели

Annual	2023
Выручка:	$1.60M
Валовая прибыль:	$-4.81M (-301.06 %)
EPS:	$-0.0562

FY	2023
Выручка:	$1.60M
Валовая прибыль:	$-4.81M (-301.06 %)
EPS:	$-0.0562

FY	2022
Выручка:	$1.67M
Валовая прибыль:	$983 000 (58.97 %)
EPS:	$-0.0419

FY	2021
Выручка:	$2.05M
Валовая прибыль:	$1.22M (59.45 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

Spectral Medical Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Spectral Medical Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.120	2011-12-19
Last Dividend	$0.120	2011-12-19
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.120	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-27)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
ZXM.TO	Dividend Junior	2023-09-22	Quarterly	11	1.98%
TWC.TO	Dividend King	2023-08-30	Quarterly	25	0.49%
MI-UN.TO	Dividend Knight	2023-09-28	Monthly	7	1.50%
CVE.TO	Dividend King	2023-09-14	Quarterly	15	1.16%
XSMC.TO	Dividend Junior	2023-06-26	Semi-Annually	6	0.57%
RLB.TO	Dividend Knight	2023-09-21	Monthly	9	1.49%
GGRO.TO	Dividend Junior	2023-06-26	Quarterly	5	0.85%
BASE.TO	Dividend Knight	2023-08-30	Monthly	6	4.24%
VRIF.TO	Dividend Knight	2023-08-31	Monthly	5	2.22%
NPRF.TO	Dividend King	2023-08-23	Monthly	6	2.55%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-9.76	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-2.99	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	1.629	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.403	0.800	-2.99	-2.39	[1 - 3]
quickRatioTTM	0.366	0.800	-2.55	-2.04	[0.8 - 2.5]
cashRatioTTM	0.288	1.500	9.51	10.00	[0.2 - 2]
debtRatioTTM	1.547	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-8.77	1.000	-4.36	-4.36	[3 - 30]
operatingCashFlowPerShareTTM	-0.0385	2.00	-0.0128	-0.0257	[0 - 30]
freeCashFlowPerShareTTM	-0.0391	2.00	-0.0196	-0.0391	[0 - 20]
debtEquityRatioTTM	-0.487	-1.500	-1.948	2.92	[0 - 2.5]
grossProfitMarginTTM	-0.321	1.000	-8.68	-8.68	[0.2 - 0.8]
operatingProfitMarginTTM	-7.32	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.330	1.000	-8.50	-8.50	[0.2 - 2]
assetTurnoverTTM	0.307	0.800	-1.289	-1.031	[0.5 - 2]
Total Score				-3.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-8.57	1.000	-0.967	0	[1 - 100]
returnOnEquityTTM	1.629	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0391	2.00	-0.0130	-0.0391	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0385	2.00	-0.0128	-0.0257	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0599	1.500	-2.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-6.71	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.542

Spectral Medical Inc

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.